In vitro activity of tigecycline and comparators (2014–2016) among key WHO ‘priority pathogens’ and longitudinal assessment (2004–2016) of antimicrobial resistance: a report from the T.E.S.T. study
Authors:
- 1 October 2018
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 52 (4) , 474-484
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015The Brazilian Journal of Infectious Diseases, 2017
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014Infection Control & Hospital Epidemiology, 2016
- The global epidemiology of carbapenemase-producing EnterobacteriaceaeVirulence, 2016
- Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011–2014)International Journal of Antimicrobial Agents, 2016
- Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoinClinical Microbiology and Infection, 2015
- Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)The Brazilian Journal of Infectious Diseases, 2013
- An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011Diagnostic Microbiology and Infectious Disease, 2013
- Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)Journal of Antimicrobial Chemotherapy, 2011
- Eight-year (2002-2009) Summary of the Linezolid (Zyvox®Annual Appraisal of potency and Spectrum; ZAAPS) Program in European CountriesJournal of Chemotherapy, 2011
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005